vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and OneSpan Inc. (OSPN). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $65.9M, roughly 1.9× OneSpan Inc.). OneSpan Inc. runs the higher net margin — 17.5% vs 3.3%, a 14.2% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs 4.1%). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 4.0%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.
NATR vs OSPN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $65.9M |
| Net Profit | $4.1M | $11.6M |
| Gross Margin | 72.5% | 73.6% |
| Operating Margin | 4.3% | 22.5% |
| Net Margin | 3.3% | 17.5% |
| Revenue YoY | 4.7% | 4.1% |
| Net Profit YoY | 1379.4% | — |
| EPS (diluted) | $0.23 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $65.9M | ||
| Q4 25 | $123.8M | $62.9M | ||
| Q3 25 | $128.3M | $57.1M | ||
| Q2 25 | $114.8M | $59.8M | ||
| Q1 25 | $113.2M | $63.4M | ||
| Q4 24 | $118.2M | $61.2M | ||
| Q3 24 | $114.6M | $56.2M | ||
| Q2 24 | $110.6M | $60.9M |
| Q1 26 | — | $11.6M | ||
| Q4 25 | $4.1M | $43.5M | ||
| Q3 25 | $5.3M | $6.5M | ||
| Q2 25 | $5.3M | $8.3M | ||
| Q1 25 | $4.7M | $14.5M | ||
| Q4 24 | $-321.0K | $28.8M | ||
| Q3 24 | $4.3M | $8.3M | ||
| Q2 24 | $1.3M | $6.6M |
| Q1 26 | — | 73.6% | ||
| Q4 25 | 72.5% | 73.6% | ||
| Q3 25 | 73.3% | 73.6% | ||
| Q2 25 | 71.7% | 73.5% | ||
| Q1 25 | 72.1% | 74.3% | ||
| Q4 24 | 72.0% | 74.0% | ||
| Q3 24 | 71.3% | 73.9% | ||
| Q2 24 | 71.4% | 66.2% |
| Q1 26 | — | 22.5% | ||
| Q4 25 | 4.3% | 19.9% | ||
| Q3 25 | 7.0% | 14.4% | ||
| Q2 25 | 3.7% | 17.6% | ||
| Q1 25 | 5.4% | 27.1% | ||
| Q4 24 | 3.8% | 19.3% | ||
| Q3 24 | 4.6% | 20.0% | ||
| Q2 24 | 5.1% | 12.5% |
| Q1 26 | — | 17.5% | ||
| Q4 25 | 3.3% | 69.2% | ||
| Q3 25 | 4.2% | 11.4% | ||
| Q2 25 | 4.6% | 13.9% | ||
| Q1 25 | 4.2% | 22.9% | ||
| Q4 24 | -0.3% | 47.1% | ||
| Q3 24 | 3.8% | 14.7% | ||
| Q2 24 | 1.2% | 10.8% |
| Q1 26 | — | $0.39 | ||
| Q4 25 | $0.23 | $1.13 | ||
| Q3 25 | $0.30 | $0.17 | ||
| Q2 25 | $0.28 | $0.21 | ||
| Q1 25 | $0.25 | $0.37 | ||
| Q4 24 | $-0.02 | $0.73 | ||
| Q3 24 | $0.23 | $0.21 | ||
| Q2 24 | $0.07 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $49.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $272.0M |
| Total Assets | $261.1M | $383.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $49.8M | ||
| Q4 25 | $93.9M | $70.5M | ||
| Q3 25 | $95.6M | $85.6M | ||
| Q2 25 | $81.3M | $92.9M | ||
| Q1 25 | $86.5M | $105.2M | ||
| Q4 24 | $84.7M | $83.2M | ||
| Q3 24 | $78.7M | $77.5M | ||
| Q2 24 | $68.7M | $63.8M |
| Q1 26 | — | $272.0M | ||
| Q4 25 | $161.6M | $271.8M | ||
| Q3 25 | $166.7M | $238.3M | ||
| Q2 25 | $163.7M | $242.5M | ||
| Q1 25 | $167.1M | $231.1M | ||
| Q4 24 | $161.0M | $212.5M | ||
| Q3 24 | $162.6M | $194.6M | ||
| Q2 24 | $156.4M | $178.6M |
| Q1 26 | — | $383.1M | ||
| Q4 25 | $261.1M | $397.7M | ||
| Q3 25 | $264.8M | $343.5M | ||
| Q2 25 | $254.9M | $357.1M | ||
| Q1 25 | $252.7M | $333.8M | ||
| Q4 24 | $240.9M | $338.7M | ||
| Q3 24 | $245.3M | $289.3M | ||
| Q2 24 | $235.8M | $286.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $28.2M |
| Free Cash FlowOCF − Capex | $7.6M | — |
| FCF MarginFCF / Revenue | 6.1% | — |
| Capex IntensityCapex / Revenue | 1.9% | — |
| Cash ConversionOCF / Net Profit | 2.41× | 2.44× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $28.2M | ||
| Q4 25 | $9.9M | $12.6M | ||
| Q3 25 | $18.5M | $11.3M | ||
| Q2 25 | $4.3M | $6.2M | ||
| Q1 25 | $2.6M | $29.4M | ||
| Q4 24 | $12.2M | $12.4M | ||
| Q3 24 | $9.6M | $14.0M | ||
| Q2 24 | $1.3M | $2.3M |
| Q1 26 | — | — | ||
| Q4 25 | $7.6M | $9.6M | ||
| Q3 25 | $16.8M | $8.8M | ||
| Q2 25 | $3.0M | $4.4M | ||
| Q1 25 | $1.5M | $27.7M | ||
| Q4 24 | $10.0M | $10.5M | ||
| Q3 24 | $7.9M | $12.0M | ||
| Q2 24 | $-2.0M | $26.0K |
| Q1 26 | — | — | ||
| Q4 25 | 6.1% | 15.3% | ||
| Q3 25 | 13.1% | 15.4% | ||
| Q2 25 | 2.6% | 7.3% | ||
| Q1 25 | 1.3% | 43.8% | ||
| Q4 24 | 8.5% | 17.1% | ||
| Q3 24 | 6.9% | 21.4% | ||
| Q2 24 | -1.9% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 4.7% | ||
| Q3 25 | 1.3% | 4.4% | ||
| Q2 25 | 1.2% | 3.1% | ||
| Q1 25 | 1.0% | 2.6% | ||
| Q4 24 | 1.9% | 3.2% | ||
| Q3 24 | 1.5% | 3.5% | ||
| Q2 24 | 3.0% | 3.7% |
| Q1 26 | — | 2.44× | ||
| Q4 25 | 2.41× | 0.29× | ||
| Q3 25 | 3.46× | 1.74× | ||
| Q2 25 | 0.81× | 0.75× | ||
| Q1 25 | 0.55× | 2.02× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | 2.21× | 1.69× | ||
| Q2 24 | 0.97× | 0.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
OSPN
| Product and license | $35.5M | 54% |
| Services and other | $30.4M | 46% |
